2026 Clinical Advances & Treatment Challenges in Solid and Hematologic Malignancies, Jacksonville
Accreditation: 6.50 ACPE Pharmacy | 6.50 ABIM MOC II | 6.50 AMA PRA Category 1 Credit™ | 6.50 Nursing Contact Hours
Venue: Hyatt Regency Jacksonville Riverfront, 225 East Coastline Drive, Jacksonville, FL, United States
Official conference page for 2026 Clinical Advances & Treatment Challenges in Solid and Hematologic Malignancies, Jacksonville. https://binaytara.org/projects/conferences/2026-jacksonville
About 2026 Clinical Advances & Treatment Challenges in Solid and Hematologic Malignancies, Jacksonville
Overview
Trusted by Thousands of Attendees
Across Our Events
Faculty and committee
Conference program and agenda
Our Agenda
Saturday, April 11th, 2026
All timings are in Eastern Time (EDT, GMT-04:00) time.
Session Chair: Pooja Advani, MD, MBBS
08:20 AM - 08:35 AM
Role of ADCs in Triple-Negative Breast Cancer – Saranya Chumsri, MD
08:35 AM - 08:50 AM
HER2-Positive Breast Cancer: Updates in First-Line Treatment – Aixa Soyano, MD
08:50 AM - 09:05 AM
SERDs in Metastatic HR Positive Breast Cancer – Dayra Carolina Avila-Lima, MD
09:05 AM - 09:35 AM
Case-based Panel Discussion
Moderators:
Shreya Ghanshyam Patel, DO
Panelists:
Saranya Chumsri, MD; Aixa Soyano, MD; Dayra Carolina Avila-Lima, MD
Session Chair: Bruna Pellini, MD
09:50 AM - 10:05 AM
Recent Updates in Management of Small Cell Lung Cancer – Shenduo Li, MD, PhD
10:05 AM - 10:20 AM
Beyond Osimertinib: Evolving treatment landscape for EGFR mutant NSCLC – Bruna Pellini, MD
10:20 AM - 10:50 AM
Cased-Based Panel Discussion
Moderators:
Shreya Ghanshyam Patel, DO
Panelists:
Bruna Pellini, MD; Shenduo Li, MD, PhD
Session Chair: Hani Babiker, MD
10:50 AM - 11:05 AM
Updates in Management of Pancreatic Cancers: Practice-Changing Paradigms – Hani Babiker, MD
11:05 AM - 11:30 AM
Targeting MSI-High in CRC in 2026 – Umair Majeed, MD, MBBS
11:30 AM - 12:00 PM
Cased-Based Panel Discussion
Moderators:
Vasu Malhotra, DO
Panelists:
Hani Babiker, MD; Umair Majeed, MD, MBBS
Session Chair: Talha Badar, MD, MBBS
01:00 PM - 01:15 PM
How to Choose the Best Initial Treatment for CLL in 2026 – Javier Pinilla-Ibarz, MD, PhD
01:15 PM - 01:30 PM
Modern Treatment of B-ALL in the Era of Immunotherapy – Rawan Faramand, MD
01:30 PM - 01:45 PM
Acute Myeloid Leukemia: Impact of ASH 2025 Updates in Community Practice – Talha Badar, MD, MBBS
01:45 PM - 02:15 PM
Case-based Panel Discussion
Moderators:
Talha Badar, MD, MBBS
Panelists:
Javier Pinilla-Ibarz, MD, PhD; Rawan Faramand, MD
Session Chair: Ricardo Daniel Parrondo, MD
02:40 PM - 02:55 PM
Treatment Sequencing in R/R Multiple Myeloma: Key Updates from ASH 2025 – Omar Castaneda, MD
02:55 PM - 03:10 PM
Modern Treatment Approach of Newly Diagnosed Multiple Myeloma – Ricardo Daniel Parrondo, MD
03:10 PM - 03:40 PM
Case-based Panel Discussion
Moderators:
Ricardo Daniel Parrondo, MD
Panelists:
Omar Castaneda, MD
Session Chair: Julio C Chavez, MD
03:40 PM - 03:55 PM
Key ASH 2025 Updates in Non-Hodgkin's Lymphomas – Madiha Iqbal, MD, MBBS
03:55 PM - 04:10 PM
Impact of Novel Agents in the Frontline Treatment of Hodgkin Lymphoma – Hun Ju Lee, MD
04:10 PM - 04:40 PM
Case-based Panel Discussion
Moderators:
Julio C Chavez, MD
Panelists:
Madiha Iqbal, MD, MBBS; Hun Ju Lee, MD